234874927	234874927	CD	B-NP	O
|	|	NNP	I-NP	O
EMCO	EMCO	NNP	I-NP	O
|	|	VBD	B-VP	O
01821065	01821065	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2387162	2387162	CD	B-NP	O
|	|	CC	I-NP	O
9/1/2005	9/1/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Congestive	Congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2005	7/15/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/21/2005	8/21/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SOLTOW	SOLTOW	NNP	B-NP	O
,	,	,	O	O
TERENCE	TERENCE	NNP	B-NP	O
897-12-01-4	897-12-01-4	CD	I-NP	O
Mo	Mo	NNP	I-NP	O
Clasmentale	Clasmentale	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/8/05	6/8/05	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BROGLEY	BROGLEY	NNP	B-NP	O
,	,	,	O	O
WILBURN	WILBURN	NNP	B-NP	O
MICHAEL	MICHAEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/4/05	10/4/05	CD	B-NP	O
by	by	IN	B-PP	O
FELCH	FELCH	NNP	B-NP	O
,	,	,	O	O
LEN	LEN	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
18816535	18816535	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/4/05	10/4/05	CD	B-NP	O
by	by	IN	B-PP	O
SUTKUS	SUTKUS	NNP	B-NP	O
,	,	,	O	O
STUART	STUART	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

PHOSLO	PHOSLO	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CALCIUM	CALCIUM	NNP	I-NP	I-protein
ACETATE	ACETATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
667	667	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
FOLATE	FOLATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FOLIC	FOLIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NNP	I-NP	O
DIOVAN	DIOVAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
CARVEDILOL	CARVEDILOL	NN	I-NP	O
6.25	6.25	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
NEPHROCAPS	NEPHROCAPS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/4/05	10/4/05	CD	B-NP	O
by	by	IN	B-PP	O
ALAMIN	ALAMIN	NNP	B-NP	O
,	,	,	O	O
NORMAN	NORMAN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NNP	B-NP	O
Aware	Aware	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/8/05	6/8/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
LASIX	LASIX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Sackrider	Sackrider	NNP	I-NP	O
at	at	IN	B-PP	O
ACH	ACH	NNP	B-NP	O
10/22/05	10/22/05	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dauphin	Dauphin	NNP	I-NP	O
at	at	IN	B-PP	O
CMC	CMC	NNP	B-NP	O
9/6/05	9/6/05	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
40	40	CD	I-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Aaron	Aaron	NNP	B-NP	O
Searl	Searl	NNP	I-NP	O
at	at	IN	B-PP	O
MJH	MJH	NNP	B-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
to	to	TO	I-VP	O
schedule	schedule	VB	I-VP	O
this	this	DT	B-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
TBA	TBA	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	B-protein
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
Hctz	Hctz	NNP	B-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Dyspnea	Dyspnea	NN	B-NP	O
and	and	CC	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Congestive	Congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Asthma	Asthma	NNP	I-NP	O
,	,	,	O	O
OSA	OSA	NNP	B-NP	O
,	,	,	O	O
CRF	CRF	NNP	B-NP	O
,	,	,	O	O
Recent	Recent	JJ	B-NP	O
multifocal	multifocal	JJ	I-NP	O
PNA	PNA	NN	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
consult	consult	VBD	B-VP	O
BRIEF	BRIEF	NNP	B-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
ID	ID	NN	B-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
dilated	dilate	VBD	B-VP	O
non-ischemic	non-ischemic	JJ	B-NP	O
CM	CM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
23	23	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
cath	cath	NN	B-NP	O
2/1	2/1	NN	I-NP	O
=	=	SYM	B-VP	O
no	no	DT	B-NP	O
CAD	CAD	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
CRF	CRF	NN	B-NP	B-protein
almost	almost	RB	B-NP	O
ESRD	ESRD	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
2/2	2/2	CD	B-NP	O
HTN	HTN	NN	I-NP	O
vs.	vs.	IN	B-PP	O
obesity	obesity	NN	B-NP	O
related	relate	VBN	B-VP	O
GS	GS	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
DVT	DVT	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/8	9/8	CD	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
hyperhomocysteinemia	hyperhomocysteinemia	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
weeks	week	NNS	I-NP	O
worsening	worsen	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
3	3	CD	I-NP	O
miles	mile	NNS	I-NP	O
flat	flat	JJ	B-NP	O
ground	ground	NN	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
50	50	CD	B-NP	O
ft.	ft.	NN	I-NP	O
flat	flat	JJ	I-NP	O
ground	ground	NN	I-NP	O
--	--	:	O	O
DX	DX	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
AND	AND	NN	I-NP	O
?	?	.	O	O

multifocal	multifocal	JJ	B-NP	O
PNA	PNA	NN	I-NP	O
vs.	vs.	IN	B-PP	O
other	other	JJ	B-NP	O
primary	primary	JJ	I-NP	O
lung	lung	NN	I-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
CRF	CRF	NN	B-NP	B-protein
almost	almost	RB	B-NP	O
ESRD	ESRD	NNP	I-NP	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
w	w	NN	I-NP	O
above	above	IN	B-PP	O
hx	hx	NN	B-NP	O
,	,	,	O	O
admitted	admit	VBD	B-VP	O
9/8	9/8	CD	B-NP	O
dx	dx	NN	I-NP	O
'd	'd	POS	B-NP	O
multifocal	multifocal	JJ	I-NP	O
PNA	PNA	NN	I-NP	O
tx	tx	NN	I-NP	O
'd	'd	MD	B-VP	O
14d	14d	VB	I-VP	O
levoflox	levoflox	NN	B-NP	O
,	,	,	O	O
D/C	D/C	NN	B-NP	O
'd	'd	MD	B-VP	O
feeling	feel	VBG	I-VP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
progressive	progressive	JJ	B-NP	O
inc	inc	NN	I-NP	O
DOE	DOE	NNP	B-NP	O
now	now	RB	B-ADVP	O
hypoxia	hypoxia	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cough/F/C	cough/F/C	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
admit	admit	NN	I-NP	O
9/8	9/8	CD	B-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
multifocal	multifocal	JJ	B-NP	O
PNA	PNA	NN	I-NP	O
,	,	,	O	O
CTA	CTA	NN	B-NP	B-protein
no	no	DT	B-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
LENIS	LENIS	NN	B-NP	O
L	L	NN	I-NP	O
peroneal	peroneal	JJ	I-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-NP	O
Heparin	Heparin	NN	I-NP	O
,	,	,	O	O
VQ	VQ	NN	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	O	O
converted	convert	VBN	B-VP	O
to	to	TO	B-PP	O
coumadin	coumadin	NN	B-NP	O
INR	INR	NN	I-NP	O
2-3	2-3	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
RV	RV	NN	I-NP	O
dsyfn	dsyfn	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
TR	TR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
then	then	RB	B-ADVP	O
F/U	F/U	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
7/9	7/9	CD	I-NP	O
EF	EF	NN	I-NP	O
23	23	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
RV	RV	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
valve	valve	NN	I-NP	B-protein
dz	dz	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
consult	consult	NN	I-NP	O
for	for	IN	B-PP	O
stable	stable	JJ	B-NP	O
CRF	CRF	NN	I-NP	O
Cr	Cr	NNP	B-NP	O
5.5-6	5.5-6	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
F/U	F/U	NN	B-NP	O
in	in	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
vascular	vascular	JJ	B-NP	O
access	access	NN	I-NP	O
but	but	CC	O	O
none	none	NN	B-NP	O
placed	place	VBN	B-VP	O
yet	yet	RB	B-ADVP	O
.	.	.	O	O

9/8	9/8	CD	B-NP	O
Ddimer	Ddimer	NN	I-NP	O
1400	1400	CD	B-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	O
2009	2009	CD	I-NP	O
,	,	,	O	O
Trop	Trop	NNP	B-NP	O
0.84	0.84	CD	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
0.54	0.54	CD	B-NP	O
not	not	RB	B-VP	O
considered	consider	VBN	I-VP	O
ischemic	ischemic	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
tx	tx	NN	I-NP	O
.	.	.	O	O

C/O	C/O	NN	B-NP	B-protein
10lb	10lb	CD	I-NP	I-protein
weight	weight	NN	I-NP	I-protein
gain	gain	NN	I-NP	I-protein
over	over	IN	B-PP	O
last	last	JJ	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
ROS	ROS	NN	B-NP	O
O/W	O/W	NNP	I-NP	O
negative	negative	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
no	no	DT	B-NP	O
F/C/CP	F/C/CP	NN	I-NP	B-protein
,	,	,	O	O
etc	etc	FW	B-ADVP	O
-RRB-	-RRB-	FW	I-ADVP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
DDimer	DDimer	NN	B-NP	O
1207	1207	CD	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	O
2917	2917	CD	I-NP	O
,	,	,	O	O
Trop	Trop	NNP	B-NP	O
not	not	RB	B-VP	O
sent	send	VBN	I-VP	O
.	.	.	O	O

--	--	:	O	O
STATUS	STATUS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
97.2	97.2	CD	I-NP	O
HR	HR	NN	I-NP	O
98-104	98-104	CD	B-NP	O
BP	BP	NN	I-NP	O
160/114	160/114	CD	B-NP	O
RR	RR	NN	I-NP	O
18	18	CD	B-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
desat	desat	VBD	B-VP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
walking	walk	VBG	B-VP	O
50	50	CD	B-NP	O
ft.	ft.	NN	I-NP	O
comfortable	comfortable	JJ	I-NP	O
breathing	breathing	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
nice	nice	JJ	B-NP	O
guy	guy	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
to	to	TO	B-VP	O
earlobe	earlobe	VB	I-VP	O
,	,	,	O	O
bibasilar	bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
S3	S3	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	O
shins	shin	NNS	I-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
PIPA	PIPA	NN	I-NP	O
--	--	:	O	O
EVENTS	EVENTS	NNS	B-NP	O
In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
Duonebs	Duoneb	NNS	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	B-protein
325	325	CD	I-NP	I-protein
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80mg	80mg	NNP	I-NP	O
PO	PO	NNP	I-NP	O
CXR	CXR	NNP	I-NP	O
:	:	:	O	O
increased	increase	VBN	B-NP	O
bilat	bilat	NN	I-NP	O
LL	LL	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
to	to	TO	B-VP	O
periphery	periphery	VB	I-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
cephalization	cephalization	NN	I-NP	O
of	of	IN	B-PP	O
vessels	vessel	NNS	B-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
opacification	opacification	NN	I-NP	O
ECG	ECG	NN	I-NP	O
:	:	:	O	O
98	98	CD	B-NP	O
bpm	bpm	NN	I-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
strain	strain	NN	B-NP	O
--	--	:	O	O
TESTS/PROCEDURES	TESTS/PROCEDURES	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
CT	CT	NNP	I-NP	O
9/10	9/10	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
compare	compare	VBP	B-VP	O
to	to	TO	B-PP	O
9/8	9/8	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
Per	Per	NN	B-NP	O
pulm	pulm	NN	I-NP	O
c/w	c/w	NN	I-NP	O
scarring/persistent	scarring/persistent	JJ	I-NP	O
changes	change	NNS	I-NP	O
after	after	IN	B-PP	O
recent	recent	JJ	B-NP	O
multifocal	multifocal	JJ	I-NP	O
PNA	PNA	NN	I-NP	O
9/8	9/8	CD	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
e/o	e/o	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
primary	primary	JJ	I-NP	O
lung	lung	NN	I-NP	O
path	path	NN	I-NP	O
,	,	,	O	O
ground	ground	NN	B-NP	O
glass	glass	NN	I-NP	O
c/w	c/w	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
--	--	:	O	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	O	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
present	present	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
and	and	CC	I-NP	O
CT	CT	NN	I-NP	O
changes	change	NNS	I-NP	O
are	be	VBP	B-VP	O
c/w	c/w	JJ	B-NP	O
scarring/changes	scarring/change	NNS	I-NP	O
from	from	IN	B-PP	O
recent	recent	JJ	B-NP	O
multifocal	multifocal	JJ	I-NP	O
PNA	PNA	NN	I-NP	O
9/8	9/8	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
additional	additional	JJ	B-NP	O
ground	ground	NN	I-NP	O
glass	glass	NN	I-NP	O
c/w	c/w	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
or	or	CC	I-NP	O
radiologic	radiologic	JJ	I-NP	O
e/o	e/o	NN	I-NP	O
primary	primary	JJ	I-NP	O
lung	lung	NN	I-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
team	team	NN	I-NP	O
assessed	assess	VBD	B-VP	O
patient	patient	NN	B-NP	O
and	and	CC	O	O
reviewed	review	VBN	B-NP	O
non	non	JJ	I-NP	O
contrast	contrast	NN	I-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
admssion	admssion	NN	I-NP	O
-	-	HYPH	O	O
they	they	PRP	B-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
current	current	JJ	B-NP	O
sx	sx	NN	I-NP	O
are	be	VBP	B-VP	O
likely	likely	JJ	B-ADJP	O
2/2	2/2	CD	B-NP	O
pulomonary	pulomonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
just	just	RB	B-ADVP	O
over	over	IN	B-PP	O
3L	3L	NN	B-NP	O
net	net	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	I-NP	O
ambulation	ambulation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
JVP	JVP	NN	I-NP	O
10cm	10cm	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
diurese	diurese	VB	I-VP	O
further	further	RBR	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
BID	BID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
his	his	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
for	for	IN	B-PP	O
2d	2d	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
was	be	VBD	B-VP	O
another	another	DT	B-NP	O
issue	issue	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
wrong	wrong	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coreg	Coreg	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
taking	take	VBG	B-VP	O
QOD	QOD	NN	B-NP	B-protein
instead	instead	RB	B-CONJP	O
of	of	IN	I-CONJP	O
BID	BID	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
a	a	DT	B-NP	O
BID	BID	NN	I-NP	O
Coreg	Coreg	NN	I-NP	O
regiments	regiment	NNS	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
much	much	RB	B-ADJP	O
better	well	RBR	I-ADJP	O
controlled	control	VBN	I-ADJP	O
.	.	.	O	O

Etiology	Etiology	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
CMP	CMP	NN	I-NP	B-protein
still	still	RB	B-ADVP	O
remains	remain	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
despite	despite	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
outpt	outpt	NN	I-NP	O
W/U	W/U	NNP	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
discrepancy	discrepancy	NN	B-NP	O
between	between	IN	B-PP	O
Echo	Echo	NNP	B-NP	O
and	and	CC	O	O
Cardiac	Cardiac	NNP	B-NP	O
MRI	MRI	NNP	I-NP	O
is	be	VBZ	B-VP	O
puzzling	puzzling	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
clean	clean	JJ	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
Lipitor	Lipitor	NN	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
function	function	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
impaired	impaired	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
vasc	vasc	NN	I-NP	O
access	access	NN	I-NP	O
placed	place	VBN	B-VP	O
yet	yet	RB	B-ADVP	O
.	.	.	O	O

Phoslo	Phoslo	NNP	B-NP	O
,	,	,	O	O
nephrocaps	nephrocap	NNS	B-NP	O
continued	continue	VBN	B-VP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
recent	recent	JJ	I-NP	I-protein
DVT	DVT	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
9/8	9/8	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	I-NP	O
INR	INR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
suspicion	suspicion	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
instructions	instruction	NNS	B-NP	O
.	.	.	O	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Be	Be	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
your	your	PRP$	B-NP	O
Coreg	Coreg	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
gets	get	VBZ	B-VP	O
worse	worse	JJR	B-ADJP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
or	or	CC	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
as	as	IN	B-SBAR	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Check	Check	VB	B-VP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Call	Call	VB	B-VP	O
you	you	PRP	B-NP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	O	O
cardiologist	cardiologist	NN	B-NP	O
Monday	Monday	NNP	B-NP	O
morning	morning	NN	I-NP	O
9/7	9/7	CD	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
this	this	DT	B-NP	O
upcoming	upcoming	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Fair	Fair	NN	B-NP	O
TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LAA	LAA	NNP	B-NP	O
,	,	,	O	O
TOM	TOM	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GP10	GP10	NNP	I-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	O
6/8/05	6/8/05	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
25	25	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

